In addition to breast and ovarian cancer, an increased risk for prostate cancer in BRCA2 PV carriers as well as pancreatic cancer in both male and female BRCA1/2 PV carriers has been recognized [15,16]. This evidence concerns the gene BRCA1 and ovarian carcinoma.